Cellyan Biotechnology (HKPD) Current Leases (2024 - 2025)
Cellyan Biotechnology (HKPD) reported Current Leases of $452940.0 for Q3 2025, down 50.27% year-over-year from $910714.0 in Q3 2024, and down 8.14% quarter-over-quarter from $493103.0 in Q1 2025.
Cellyan Biotechnology (HKPD) Current Leases (2024 - 2025) Analysis & Trends
Cellyan Biotechnology (HKPD) has 2 years of Current Leases data on file, last reported at $452940.0 in Q3 2025.
- Current Leases for Q3 2025 came in at $452940.0, down 50.27% year-over-year; the trailing twelve-month figure through Sep 2025 was $452940.0 (down 50.27% YoY), and the FY2025 annual result was $493103.0, down 22.29% from the prior year.
- Current Leases retreated to $452940.0 in Q3 2025 per HKPD's latest filing, from $493103.0 in the prior quarter.
- Over five years, Current Leases peaked at $910714.0 in Q3 2024 and troughed at $452940.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | 41,683.00 |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | 287.00 Mn |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | - |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | - |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | 78.00 Mn |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | - |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | 918,000.00 |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | 2.70 Mn |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | 204,588.00 |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | 452,940.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 452,940.00 |
| Mar 31, 2025 | 493,103.00 |
| Sep 30, 2024 | 910,714.00 |
| Mar 31, 2024 | 634,504.00 |